E-LIB Suche - Ergebnisse für: Strickler, John

1

Sotorasib with panitumumab in chemotherapy-refractory KRASG..:

Kuboki, Yasutoshi ; Fakih, Marwan ; Strickler, John...
Nature Medicine. 30 (2024) 1 - p. 265-270 , 2024

Link: https://doi.org/10.1038/..

2

Trends in Receipt of Adjuvant Chemotherapy and its Impact o..:

Rhodin, Kristen E. ; Liu, Annie ; Bartholomew, Alex...
Annals of Surgical Oncology. 30 (2023) 8 - p. 4813-4821 , 2023

Link: https://doi.org/10.1245/..

3

ASO Visual Abstract: Trends in Receipt of Adjuvant Chemothe..:

Rhodin, Kristen E. ; Liu, Annie ; Bartholomew, Alex...
Annals of Surgical Oncology. 30 (2023) 8 - p. 4824-4825 , 2023

Link: https://doi.org/10.1245/..

4

A quality improvement initiative to increase genetic testin..:

Peters, Pamela ; Gonzalez, Rafael ; Havrilesky, Laura...
Gynecologic Oncology. 166 (2022) - p. S152 , 2022

Link: https://doi.org/10.1016/..

5

A randomized phase II trial of nab‐paclitaxel and gemcitabi..:

Hu, Zishuo Ian ; Bendell, Johanna C. ; Bullock, Andrea...
Cancer Medicine. 8 (2019) 11 - p. 5148-5157 , 2019

Link: https://doi.org/10.1002/..

6

MA09.09 First-In-Human Phase 1 Study of ABBV-399, an Antibo..:

Angevin, Eric ; Strickler, John ; Weekes, Colin...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S395-S396 , 2017

Link: https://doi.org/10.1016/..

7

Safety, pharmacokinetics, and pharmacodynamic properties of..:

Hurwitz, Herbert I. ; Smith, David C. ; Pitot, Henry C....
Cancer Chemotherapy and Pharmacology. 75 (2015) 4 - p. 851-859 , 2015

Link: https://doi.org/10.1007/..

8

A Study to Learn how Well Tucatinib Plus Trastuzumab Works ..:

Strickler, John H ; Bekaii-Saab, Tanios S
Future Oncology. 20 (2024) 8 - p. 409-421 , 2024

Link: https://doi.org/10.2217/..

9

Racial and ethnic disparities in genomic testing among lung..:

Meernik, Clare ; Raveendran, Yadurshini ; Kolarova, Michaela...
JNCI: Journal of the National Cancer Institute. 116 (2024) 6 - p. 812-828 , 2024

Link: https://doi.org/10.1093/..

10

Impact of Anti-EGFR Therapies on HER2-Positive Metastatic C..:

Bekaii-Saab, Tanios S ; Lach, Krzysztof ; Hsu, Ling-I...
The Oncologist. 28 (2023) 10 - p. 885-893 , 2023

Link: https://doi.org/10.1093/..

11

First-in-human study of oleclumab, a potent, selective anti..:

Bendell, Johanna ; LoRusso, Patricia ; Overman, Michael...
Cancer Immunology, Immunotherapy. 72 (2023) 7 - p. 2443-2458 , 2023

Link: https://doi.org/10.1007/..

12

Management of Microsatellite Instability High (MSI-H) Gastr..:

Zhou, Katherine I. ; Hanks, Brent A. ; Strickler, John H.
Journal of Gastrointestinal Cancer. 55 (2023) 2 - p. 483-496 , 2023

Link: https://doi.org/10.1007/..

13

Prevalence of KRAS G12C Mutation and Co-mutations and Assoc..:

Strickler, John H ; Yoshino, Takayuki ; Stevinson, Kendall...
The Oncologist. 28 (2023) 11 - p. e981-e994 , 2023

Link: https://doi.org/10.1093/..

14

Tucatinib plus trastuzumab for chemotherapy-refractory, HER..:

Strickler, John H ; Cercek, Andrea ; Siena, Salvatore...
The Lancet Oncology. 24 (2023) 5 - p. 496-508 , 2023

Link: https://doi.org/10.1016/..

15

Concordance Between Genomic Alterations Detected by Tumor a..:

Green, Michelle F ; Watson, Catherine H ; Tait, Sarah...
The Oncologist. 28 (2023) 1 - p. 33-39 , 2023

Link: https://doi.org/10.1093/..